A notice on change in labels design of the following products from Abbott Laboratories Ltd.:

  • SYNTHROID 50 µg 90 Tablets
  • SYNTHROID 100 µg 90 Tablets
    As part of a global rebranding of all products marketed by Abbot worldwide, the company wishes to announce a change in label design in Israel of the product Sintroaid (Levothyroxine Sodium) 50 µg and 100 µg for the treatment of hypothyroidism.
    It should be noted that there is no change in the products or their composition. This change is in the external label only.
    For more information, please contact Abbott Laboratories Ltd, Kiryat Atidim, Building 4, PO Box 58099, Tel Aviv, or by phone 03-7691415.
A notice on a change in labels design of Sintroaid tablets 50 and 100 µg